|

Recall: Nostrilla Nasal Decongestant—bacteria contamination

Consumer Reports News: October 21, 2011 03:53 PM

Insight Pharmaceuticals has recalled 34,092 bottles of Nostrilla, a nasal decongestant (oxymetazoline) spray used to relieve nasal discomfort caused by colds, because the spray may contain bacteria.

The bacteria, Burkholderia cepacia, may cause serious infection in individuals with a compromised immune system or chronic lung condition, such as cystic fibrosis.

Nostrilla Nasal Decongestant was distributed nationwide through retail outlets and pharmacies. The spray comes in a half ounce, plastic bottle marked with an expiration date of May, 2014.The affected products also have lot number 11G075, and UPC code 6373673005.

Consumers who purchased Nostrilla can return the product, and also contact the company at 877-546-9059 for more information. Consumers should also contact their physician or healthcare provider if they experience any problems that may be related to taking the recalled nasal spray. Healthcare professionals and patients can report adverse events or side effects to the U.S. Food and Drug Administration's MedWatch Safety Information and Adverse Event Reporting Program, either by visiting www.fda.gov/MedWatch/report.htm, or call by calling 800-332-1088 to get a form sent to you by mail.

Nostrilla Nasal Decongestant: Recall - Bacterial Contamination [FDA]

Maggie Shader

   

E-mail Newsletters

FREE e-mail Newsletters! Choose from cars, safety, health, and more!
Already signed-up?
Manage your newsletters here too.

Recalls News

Connect

and safety with
subscribers and fans

Follow us on:

Cars

Cars New Car Price Report
Find out what the dealers don't want you to know! Get dealer pricing information on a new car with the New Car Price Report.

Order Your Report

Mobile

Mobile Get Ratings on the go and compare
while you shop

Learn more